PACB(Pacific Biosciences of California, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $130.51M | $128.30M | $200.52M | $154.01M | $160.00M |
| 毛利润 | $58.86M | $49.03M | $52.78M | $37.28M | $45.78M |
| 营业利润 | −$210.44M | −$307.20M | −$334.47M | −$474.31M | −$553.86M |
| 净利润 | −$181.22M | −$314.25M | −$306.74M | −$309.85M | −$546.38M |
| 经营现金流 | −$111.18M | −$263.21M | −$259.17M | −$206.06M | −$111.21M |
| 自由现金流 | −$117.11M | −$279.96M | −$268.02M | −$212.25M | −$113.92M |
| 摊薄每股收益 | $-0.89 | $-1.40 | $-1.21 | $-1.59 | $-1.82 |